A meta-analysis reveals that the risk is present for most surgeries.
Read More »Study Suggests Caution Needed When Using Premixed Insulin in the Hospital
New study suggests that in hospital patients with T2DM, premixed insulin provides similar glycemic control as a basal-bolus insulin regimen.
Read More »Safety and Efficacy of Vildagliptin and Sitagliptin in Renally Impaired Type 2 Diabetics
Dipeptidyl peptidase-4 (DPP4) inhibitors are generally well-tolerated for use in patients with severe renal impairment...
Read More »Best Plan for Patient May Not Be The Recommended Plan
Female, type 1 diabetes for 42 years, 58 years of age, lives with husband and dog. Patient has hypoglycemic unawareness. We regularly readjust her treatment plan and have recommended CGM for this patient on numerous occasions, but she refuses, stating her dog wakes her up if and when she has ...
Read More »Efficacy and Safety of an SGLT-2 Inhibitor with Insulin for Type 2s
Canagliflozin appears to offer significant benefits when used in conjunction with insulin therapy.
Read More »FDA Panel Recommends New CV Safety Warnings on Onglyza and Nesina DPP-4s
Updated label information recommendation is in light of completed cardiovascular-outcomes studies.
Read More »Clinical Trial Examines Safety, Effectiveness of Drug to Treat Binge Eating Disorder
Lisdexamfetamine dimesylate, used to treat attention-deficit/hyperactivity disorder, was effective compared with placebo in decreasing binge-eating (BE) days in patients… At some doses, the medication lisdexamfetamine dimesylate, a drug approved to treat attention-deficit/hyperactivity disorder, was effective compared with placebo in decreasing binge-eating (BE) days in patients with binge-eating disorder (BED), a ...
Read More »Glucagon Label Contributes to Confusion
From our partners at the Institute for Safe Medication Practices (ISMP.org): A nurse gave orange juice to a patient with a blood glucose level of less than 50 mg/dL, but it did not raise the glucose level much, so he administered a dose of IV GLUCAGON EMERGENCY (glucagon) per policy. ...
Read More »“Do Not Crush, Chew or Cut”
From the Institute for Safe Medication Practices (ISMP): When a patient is prescribed a timed release medication such as Glucotrol XL or Glucophage XR, clinicians need to ensure that the patients understand that they should not crush, chew or cut these pills. The medications must be swallowed whole. In one case ...
Read More »Dosing Error Due to Accent Misinterpretation
When reviewing the medical record of a hospital patient prior to meeting with her for a diabetes consult, I noted that the doctor had ordered 46 units of Lantus to be given daily at bedtime. When I went in to visit with the patient, she had a very strong accent ...
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.